National Cancer Institute Breast Cancer Steering Committee Working Group Report on Meaningful and Appropriate End Points for Clinical Trials in Metastatic Breast Cancer | Journal of Clinical Oncology
Ovarian cancer clinical trial endpoints: Society of Gynecologic Oncology white paper
Determining lines of therapy in patients with solid cancers: a proposed new systematic and comprehensive framework | British Journal of Cancer
Clinical Trial Endpoints in Cancer Research: Four Terms You Should Know
Clinical Trial Endpoints for Oncology Studies
Margin status and survival outcomes after breast cancer conservation surgery: prospectively registered systematic review and meta-analysis | The BMJ
Extrapolation from Progression Free Survival to Overall Survival in O…
Progression Free Survival - an overview | ScienceDirect Topics
Event-free and overall survival following neoadjuvant weekly paclitaxel and dose-dense AC +/- carboplatin and/or bevacizumab in triple-negative breast. - ppt download
JCM | Free Full-Text | Comprehensive Characterization of Human Lung Large Cell Carcinoma Identifies Transcriptomic Signatures with Potential Implications in Response to Immunotherapy
Frontiers | What Is Long-Term Survival and Which First-Line Immunotherapy Brings Long-Term Survival for Advanced Wild-Type Non-Small Cell Lung Cancer: A Network Meta-Analysis Based on Integrated Analysis
Intermediate clinical endpoints: A bridge between progression‐free survival and overall survival in ovarian cancer trials - Matulonis - 2015 - Cancer - Wiley Online Library
Biochemical Failure Is Not a Surrogate End Point for Overall Survival in Recurrent Prostate Cancer: Analysis of NRG Oncology/RTOG 9601 | Journal of Clinical Oncology
Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients - The Lancet Oncology
Endpoints Used in Clinical Trials Endpoint Definition Overall survival... | Download Table
Time to second subsequent therapy as an endpoint. Progression-free... | Download Scientific Diagram
A Primer on RECIST 1.1 for Oncologic Imaging in Clinical Drug Trials | Radiology: Imaging Cancer
Estimating progression-free survival in patients with glioblastoma using routinely collected data | SpringerLink
Kaplan–Meier plots for overall survival among patients who were... | Download Scientific Diagram
Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer | NEJM
Survival in oncology reimbursement decision-making | CMAR
Outcomes and endpoints in trials of cancer treatment: the past, present, and future - The Lancet Oncology
